Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

Cognitive Behavioral Treatments for Depression in Chronic Illness
Cognitive Behavioral Treatments for Depression in Patients With Chronic Illness
Status: Enrolling
Updated:  11/15/2012
Glendale Adventist Medical Center
mi
from
Glendale, CA
Cognitive Behavioral Treatments for Depression in Chronic Illness
Cognitive Behavioral Treatments for Depression in Patients With Chronic Illness
Status: Enrolling
Updated: 11/15/2012
Glendale Adventist Medical Center
mi
from
Glendale, CA
Click here to add this to my saved trials
Cognitive Behavioral Treatments for Depression in Chronic Illness
Cognitive Behavioral Treatments for Depression in Patients With Chronic Illness
Status: Enrolling
Updated:  11/15/2012
Duke Univ Med Ctr
mi
from
Durham, NC
Cognitive Behavioral Treatments for Depression in Chronic Illness
Cognitive Behavioral Treatments for Depression in Patients With Chronic Illness
Status: Enrolling
Updated: 11/15/2012
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Investigate Efficacy & Safety of RO4995819 vs. Placebo as Adjunct Tx in Patients w/Major Depressive Disorder
A Multi-center Randomized Double-blind Placebo-controlled Parallel-group Study to Investigate Efficacy and Safety of RO4995819 vs Placebo, as Adjunct Therapy in Patients w/Major Depressive Disorder
Status: Enrolling
Updated:  11/27/2012
Stanford University Department of Psychiatry
mi
from
Stanford, CA
Investigate Efficacy & Safety of RO4995819 vs. Placebo as Adjunct Tx in Patients w/Major Depressive Disorder
A Multi-center Randomized Double-blind Placebo-controlled Parallel-group Study to Investigate Efficacy and Safety of RO4995819 vs Placebo, as Adjunct Therapy in Patients w/Major Depressive Disorder
Status: Enrolling
Updated: 11/27/2012
Stanford University Department of Psychiatry
mi
from
Stanford, CA
Click here to add this to my saved trials
e-Counseling for COPD
Psychosocial-Behavioral Therapy for Patients With Advanced COPD and Depression
Status: Enrolling
Updated:  11/29/2012
Univ of Washington
mi
from
Seattle, WA
e-Counseling for COPD
Psychosocial-Behavioral Therapy for Patients With Advanced COPD and Depression
Status: Enrolling
Updated: 11/29/2012
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram
Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram
Status: Enrolling
Updated:  12/10/2012
Emory University School of Medicine: Wesley Woods Health Center
mi
from
Atlanta, GA
Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram
Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram
Status: Enrolling
Updated: 12/10/2012
Emory University School of Medicine: Wesley Woods Health Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram
Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram
Status: Enrolling
Updated:  12/10/2012
Tufts Medical Center
mi
from
Boston, MA
Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram
Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram
Status: Enrolling
Updated: 12/10/2012
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram
Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram
Status: Enrolling
Updated:  12/10/2012
Duke University School of Medicine
mi
from
Durham, NC
Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram
Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram
Status: Enrolling
Updated: 12/10/2012
Duke University School of Medicine
mi
from
Durham, NC
Click here to add this to my saved trials
A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients
Status: Enrolling
Updated:  12/12/2012
Massachusetts General Hospital
mi
from
Boston, MA
A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients
Status: Enrolling
Updated: 12/12/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Los Angeles, CA
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Miami, FL
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Athens, GA
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Athens, GA
Click here to add this to my saved trials
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Chicago, IL
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Indianapolis, IN
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Topeka, KA
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Topeka, KA
Click here to add this to my saved trials
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Boston, MA
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Las Vegas, NV
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Bridgewater, NJ
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Bridgewater, NJ
Click here to add this to my saved trials
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Santa Fe, NM
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Santa Fe, NM
Click here to add this to my saved trials
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Brooklyn, NY
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Chapel Hill, NC
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Cincinnati, OH
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Muskogee, OK
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Muskogee, OK
Click here to add this to my saved trials
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Philadelphia, PA
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Fort Worth, TX
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
American Fork, UT
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
American Fork, UT
Click here to add this to my saved trials
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Seattle, WA
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated:  1/11/2013
Clinical Research Facility
mi
from
Burlington, WI
A Study in Prevention of Re-emergence of Depression Symptoms
LY2216684 Compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder
Status: Enrolling
Updated: 1/11/2013
Clinical Research Facility
mi
from
Burlington, WI
Click here to add this to my saved trials
Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance
Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance
Status: Enrolling
Updated:  1/14/2013
University Hospitals of Cleveland
mi
from
Cleveland, OH
Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance
Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance
Status: Enrolling
Updated: 1/14/2013
University Hospitals of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated:  1/17/2013
Clinical Research Facility
mi
from
Birmingham, AL
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated: 1/17/2013
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated:  1/17/2013
Clinical Research Facility
mi
from
Phoenix, AZ
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated: 1/17/2013
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated:  1/17/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated: 1/17/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated:  1/17/2013
Clinical Research Facility
mi
from
Bridgeport, CT
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated: 1/17/2013
Clinical Research Facility
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated:  1/17/2013
Clinical Research Facility
mi
from
Washington,
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated: 1/17/2013
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated:  1/17/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated: 1/17/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated:  1/17/2013
Clinical Research Facility
mi
from
Decatur, GA
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated: 1/17/2013
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated:  1/17/2013
Clinical Research Facility
mi
from
Park Ridge, IL
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated: 1/17/2013
Clinical Research Facility
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated:  1/17/2013
Clinical Research Facility
mi
from
Metairie, LA
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated: 1/17/2013
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated:  1/17/2013
Clinical Research Facility
mi
from
Baltimore, MD
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated: 1/17/2013
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated:  1/17/2013
Clinical Research Facility
mi
from
Boston, MA
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated: 1/17/2013
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated:  1/17/2013
Clinical Research Facility
mi
from
Jackson, MS
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated: 1/17/2013
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated:  1/17/2013
Clinical Research Facility
mi
from
St. Joseph, MO
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated: 1/17/2013
Clinical Research Facility
mi
from
St. Joseph, MO
Click here to add this to my saved trials
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated:  1/17/2013
Clinical Research Facility
mi
from
Newark, NJ
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated: 1/17/2013
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated:  1/17/2013
Clinical Research Facility
mi
from
Albuquerque, NM
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated: 1/17/2013
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated:  1/17/2013
Clinical Research Facility
mi
from
New York, NY
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated: 1/17/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated:  1/17/2013
Clinical Research Facility
mi
from
Cleveland, OH
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated: 1/17/2013
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated:  1/17/2013
Clinical Research Facility
mi
from
Tulsa, OK
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated: 1/17/2013
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated:  1/17/2013
Clinical Research Facility
mi
from
Portland, OR
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated: 1/17/2013
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated:  1/17/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated: 1/17/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated:  1/17/2013
Clinical Research Facility
mi
from
Chattanooga, TN
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated: 1/17/2013
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated:  1/17/2013
Clinical Research Facility
mi
from
Dallas, TX
Effect of Lu AA21004 Versus Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder
A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Flexible-Dose Study Evaluating the Effect of Lu AA21004 vs Escitalopram on Sexual Functioning in Adults With Well-Treated Major Depressive Disorder Experiencing Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Status: Enrolling
Updated: 1/17/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials